Sanofi India Limited, (Previously known as Aventis Pharma Limited) was incorporated in May, 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.

Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target of €114.00. The company’s shares closed yesterday ...

Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis. Despite Sanofi-Synthélabo’s size, the company found itself forced to partner with larger pharmaceutical ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Sanofi India Ltd share price previously? Sanofi India Ltd share price was up by 1.51% from the previous closing ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

Sanofi Consumer Healthcare India Ltd share price was up by 0.20% from the previous closing price of ₹4,879.60. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi Consumer ...

Also Read: Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood ...

In the meantime, banks face an agonizing few months at the mercy of macroeconomic surprises and changeable markets. Representatives at CD&R, Citigroup, Goldman Sachs and Morgan Stanley declined to ...

Twenty-two lenders including Citigroup Inc., Goldman Sachs Group Inc. and Morgan Stanley extended an upfront commitment to CD&R last year so the firm could buy part of Sanofi SA’s consumer arm ...

Sanofi estimates that the annual cost for a typical patient will be around $280,000 per year before discounts or rebates, in line with other drugs used to treat rare, chronic diseases.